(Q33926675)

30 July 2017

3 references

31 July 2020

1 February 2021

6 October 2022

0 references

Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis (English)

1 reference

inflammatory bowel diseases

30 July 2017

0 references

11 references

21 March 2019

21 June 2019

28 September 2019

18 October 2019

28 November 2019

11 December 2019

13 December 2019

17 December 2019

31 July 2020

1 February 2021

6 October 2022

irritable bowel syndrome

10 references

21 March 2019

21 June 2019

28 September 2019

18 October 2019

28 November 2019

11 December 2019

13 December 2019

17 December 2019

31 July 2020

6 October 2022

1 reference

28 September 2019

fluids and secretions

1 reference

18 October 2019

1 reference

28 November 2019

1 reference

11 December 2019

1 reference

13 December 2019

1 reference

17 December 2019

2 references

31 July 2020

1 February 2021

1 reference

Xing-lu Zhou

1

1 reference

30 July 2017

Wen Xu

2

1 reference

30 July 2017

Xiao-xiao Tang

3

1 reference

30 July 2017

Lai-sheng Luo

4

1 reference

30 July 2017

Jiang-feng Tu

5

1 reference

30 July 2017

Chen-jing Zhang

6

1 reference

30 July 2017

Xiang Xu

7

1 reference

30 July 2017

Qin-dong Wu

8

1 reference

30 July 2017

Wen-sheng Pan

9

1 reference

30 July 2017

language of work or name

1 reference

7 July 2014

12 references

30 July 2017

21 March 2019

21 June 2019

28 September 2019

18 October 2019

28 November 2019

11 December 2019

13 December 2019

17 December 2019

31 July 2020

1 February 2021

6 October 2022

12 references

30 July 2017

21 March 2019

21 June 2019

28 September 2019

18 October 2019

28 November 2019

11 December 2019

13 December 2019

17 December 2019

31 July 2020

1 February 2021

6 October 2022

14

1 reference

30 July 2017

page(s)

121

1 reference

Creative Commons Attribution 4.0 International

30 July 2017

copyright license

11 references

21 March 2019

21 June 2019

28 September 2019

18 October 2019

28 November 2019

11 December 2019

13 December 2019

17 December 2019

31 July 2020

1 February 2021

on focus list of Wikimedia project

6 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Lactoferrin--50 years on.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Systematic reviews of diagnostic test accuracy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Review of fecal biomarkers in inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Fecal lactoferrin: a new parameter to monitor infliximab therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

The diagnostic odds ratio: a single indicator of test performance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Measuring inconsistency in meta-analyses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Bias in meta-analysis detected by a simple, graphical test

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Meta-analysis in clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Measurement of fecal lactoferrin as a marker of fecal leukocytes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105129

Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-230X-14-121

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-230X-14-121

Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-230X-14-121

Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome

21 January 2018

1 reference

12 December 2020

Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis

1 reference

12 December 2020

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease

1 reference

12 December 2020

Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

1 reference

12 December 2020

Accuracy of four fecal assays in the diagnosis of colitis

1 reference

12 December 2020

[Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis]

1 reference

12 December 2020

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

12 December 2020

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

12 December 2020

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

12 December 2020

Relationship between fecal lactoferrin and inflammatory bowel disease

1 reference

12 December 2020

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease

1 reference

12 December 2020

World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010

1 reference

12 December 2020

Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins

1 reference

12 December 2020

Simplifying Likelihood Ratios.

1 reference

12 December 2020

Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-14-121

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference